Interpace Biosciences Inc
OTC:IDXG
Interpace Biosciences Inc
Total Equity
Interpace Biosciences Inc
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Interpace Biosciences Inc
OTC:IDXG
|
Total Equity
-$14.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Total Equity
$926m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-15%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Equity
$6.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
CVS Health Corp
NYSE:CVS
|
Total Equity
$74B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Total Equity
$41.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
15%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Equity
$8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
12%
|
See Also
What is Interpace Biosciences Inc's Total Equity?
Total Equity
-14.6m
USD
Based on the financial report for Mar 31, 2024, Interpace Biosciences Inc's Total Equity amounts to -14.6m USD.
What is Interpace Biosciences Inc's Total Equity growth rate?
Total Equity CAGR 1Y
9%
Over the last year, the Total Equity growth was 9%.